<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>Trials via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Trials' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Trials&t=Trials&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 18 Mar 2010 14:40:19 +0100</lastBuildDate>
        <item>
            <title>JinQi-Jiangtang tablet, a Chinese patent medicine, for pre-diabetes: a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=3348329&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F27</link>
            <description>DiscussionThe aim of this study is to evaluate the effectiveness and safety of JinQi JiangTang (JQJT) tablets for the treatment of patients with pre-diabetes.Trial registrationChinese clinical trials register ChiCTR-TRC-00000401 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3348329</comments>
            <pubDate>Wed, 10 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3348329</guid>        </item>
        <item>
            <title>Protocol for a pilot randomised controlled clinical trial to compare the effectiveness of a graduated three layer straight tubular bandaging system when compared to a standard short stretch compression bandaging system in the management of people with venous ulceration: 3VSS2008</title>
            <link>http://www.medworm.com/index.php?rid=3348330&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F26</link>
            <description>This study will help answer the question whether the 3L compression system or the SS compression system is associated with better outcomes.Trial Registration: ACTRN12608000599370 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3348330</comments>
            <pubDate>Tue, 09 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3348330</guid>        </item>
        <item>
            <title>Correction: Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices</title>
            <link>http://www.medworm.com/index.php?rid=3324712&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F23</link>
            <description>Correction to Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3324712</comments>
            <pubDate>Tue, 02 Mar 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3324712</guid>        </item>
        <item>
            <title>Applicability and generalisability of the results of systematic reviews to public health practice and policy: a systematic review</title>
            <link>http://www.medworm.com/index.php?rid=3313151&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F20</link>
            <description>Conclusions:
Our study highlighted the lack of consideration of applicability of results in systematic reviews of research into 2 public health priorities: tobacco consumption and HIV infection. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3313151</comments>
            <pubDate>Fri, 26 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3313151</guid>        </item>
        <item>
            <title>Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trial</title>
            <link>http://www.medworm.com/index.php?rid=3313150&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F21</link>
            <description>Background:
In Major Depressive Disorder (MDD), the traditional belief of a delayed onset of antidepressants' effects has lead to the concept of current guidelines that treatment durations should be between 3-8 weeks before medication change in case of insufficient outcome. Post hoc analyses of clinical trials, however, have shown that improvement usually occurs within the first 10-14 days of treatment and that such early improvement (Hamilton Depression Rating Scale [HAMD] decrease [greater than or equal to]20%) has a substantial predictive value for final treatment outcome. Even more important, non-improvement (HAMD decrease (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3313150</comments>
            <pubDate>Fri, 26 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3313150</guid>        </item>
        <item>
            <title>Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=3299933&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F19</link>
            <description>This study investigates whether long-term daily bright light prevents worsening of sleep-wake rhythms and depressive symptoms in elderly people with memory complaints. Patients with early Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) and Subjective Memory Complaints (SMC), between the ages of 50 and 75, are included in a randomized double-blind placebo-controlled trial. For the duration of two years, patients are exposed to ~10,000 lux in the active condition or ~300 lux in the placebo condition, daily, for two half-hour sessions at fixed times in the morning and evening. Neuropsychological, behavioral, physiological and endocrine measures are assessed at baseline and follow-up every five to six months.DiscussionIf bright light therapy attenuates the worsening of sleep-wake rhy...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3299933</comments>
            <pubDate>Tue, 23 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3299933</guid>        </item>
        <item>
            <title>A systematic review of techniques and interventions for improving adherence to inclusion and exclusion criteria during enrolment into randomised controlled trials</title>
            <link>http://www.medworm.com/index.php?rid=3296264&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F17</link>
            <description>Conclusions:
Our systematic search yielded only one technique or intervention shown to improve adherence to eligibility criteria during enrolment into RCTs. Given the potential harm involved in recruiting patients into a clinical trial in violation of key eligibility criteria, future research is needed to better inform those conducting clinical trials of how best to prevent enrolment errors (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296264</comments>
            <pubDate>Tue, 23 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3296264</guid>        </item>
        <item>
            <title>The effectiveness of joint crisis plans for people with borderline personality disorder: protocol for an exploratory randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=3296263&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F18</link>
            <description>DiscussionResults of this trial will help to clarify the potential beneficial effects of JCPs for people with BPD and provide information to design a definitive trial.Trial Registration: Current Controlled Trials ISRCTN12440268 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3296263</comments>
            <pubDate>Tue, 23 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3296263</guid>        </item>
        <item>
            <title>The randomized shortened dental arch study (RaSDA): design and protocol</title>
            <link>http://www.medworm.com/index.php?rid=3285693&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F15</link>
            <description>DiscussionThe particular value of this trial is the adaptation of common design components to the very specific features of complex dental prosthetic treatments. The pilot trial proved to be indispensable because it led to a number of adjustments in the study protocol that considerably improved the practicability. The expected results are of high clinical relevance and will show the efficacy of two common treatment approaches in terms of oral health. An array of secondary outcome measures will deliver valuable supplementary information. If the results can be implemented in the clinical practice, the daily dental care should strongly profit thereof.Trial registration: The trial is registered at ClinicalTrials.gov under ISRCTN68590603 (pilot trial) and ISRCTN97265367 (main trial). (Source: T...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3285693</comments>
            <pubDate>Fri, 19 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3285693</guid>        </item>
        <item>
            <title>Rationale and design of the ADDITION-Leicester study, a systematic screening programme and Randomised Controlled Trial of multi-factorial cardiovascular risk intervention in people with Type 2 Diabetes Mellitus detected by screening</title>
            <link>http://www.medworm.com/index.php?rid=3285692&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F16</link>
            <description>DiscussionADDITION-Leicester is the largest multiethnic (targeting &gt;30% South Asian recruitment) community T2DM and vascular risk screening programme in the UK. By assessing feasibility and efficacy of T2DM screening, it will inform national disease prevention policy and contribute significantly to our understanding of the health care needs of UK South Asians.Trial registration: Clinicaltrial.gov (NCT00318032). (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3285692</comments>
            <pubDate>Fri, 19 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3285692</guid>        </item>
        <item>
            <title>Effects of a mouthwash with chlorine dioxide on oral malodor and salivary bacteria a randomized placebo-controlled 7-day trial</title>
            <link>http://www.medworm.com/index.php?rid=3264560&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F14</link>
            <description>DiscussionThe baseline oral condition in healthy subjects in the 2 groups did not differ significantly. After rinsing with the mouthwash containing ClO2 for 7 days, morning bad breath decreased as measured by the OM and reduced the concentrations of H2S, CH3SH and (CH3)2S measured by GC, were found. Moreover ClO2 mouthwash used over a 7-day period appeared effective in reducing plaque, tongue coating accumulation and the counts of Fusobacterium nucleatum in saliva. Future research is needed to examine long-term effects, as well as effects on periodontal diseases and plaque accumulation in a well-defined sample of halitosis patients and broader population samples.Trial registration: ClinicalTrials.gov NCT00748943 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3264560</comments>
            <pubDate>Fri, 12 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3264560</guid>        </item>
        <item>
            <title>Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic Fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=3245463&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F11</link>
            <description>Conclusions:
This work demonstrates the importance of feasibility studies in preparation for multicentre clinical trials. It confirmed the uncertainty amongst clinicians and patients about the clinical question, enabled assessment of the number of potentially eligible patients, the proportion of patients and clinicians prepared to participate and aspects of trial design which might encourage this. It showed that a clinical trial was feasible, but only if patients were recruited from across United Kingdom. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3245463</comments>
            <pubDate>Fri, 05 Feb 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3245463</guid>        </item>
        <item>
            <title>Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers</title>
            <link>http://www.medworm.com/index.php?rid=3218500&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F9</link>
            <description>In recognition of the benefits of transparent reporting, many peer-reviewed journals require that their authors be prepared to share their raw, unprocessed data with other scientists and/or state the availability of raw data in published articles. But little information on how data should be prepared for publication - or sharing - has emerged. In clinical research patient privacy and consent for use of personal health information are key considerations, but agreed-upon definitions of what constitutes anonymised patient information do not appear to have been established. We aim to address this issue by providing practical guidance for those involved in the publication process, by proposing a minimum standard for de-identifying datasets for the purposes of publication in a peer-reviewed biom...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3218500</comments>
            <pubDate>Fri, 29 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3218500</guid>        </item>
        <item>
            <title>The B-VITAGE trial: A randomized trial of homocysteine lowering treatment of depression in later life</title>
            <link>http://www.medworm.com/index.php?rid=3202737&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F8</link>
            <description>Conclusions:
The results of this trial will clarify whether the systematic use of B-vitamins improves the response of older adults to standard antidepressant treatment. We anticipate that our findings will have implications for clinical practice and health policy development.Trial RegistrationThe trial is registered with the Australian Clinical Trials Registry,trial number ACTRN12609000256279. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3202737</comments>
            <pubDate>Mon, 25 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3202737</guid>        </item>
        <item>
            <title>Improving the management of non-ST elevation acute coronary syndromes: systematic evaluation of a quality improvement programme European QUality Improvement Programme for Acute Coronary Syndrome: The EQUIP-ACS project</title>
            <link>http://www.medworm.com/index.php?rid=3173815&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F5</link>
            <description>DiscussionIf we can demonstrate important improvements in the quality of patient care as a result of a quality improvement programme, this could lead to a greater acceptance that such programmes should be incorporated into routine health training for health professionals and hospital managers.Trial registration: Clinicaltrials.gov NCT00716430 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3173815</comments>
            <pubDate>Thu, 14 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3173815</guid>        </item>
        <item>
            <title>Alberta Diabetes and Physical Activity Trial (ADAPT): A randomized theory-based efficacy trial for adults with type 2 diabetes - rationale, design, recruitment, evaluation, and dissemination</title>
            <link>http://www.medworm.com/index.php?rid=3165462&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F4</link>
            <description>DiscussionADAPT will determine whether tailored but low-cost interventions can lead to sustainable increases in PA behaviours. The results may have implications for practitioners in designing and implementing theory-based physical activity promotion programs for this population.Clinical Trials Registration: ClinicalTrials.gov identifier: NCT00221234 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3165462</comments>
            <pubDate>Tue, 12 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3165462</guid>        </item>
        <item>
            <title>Losartan therapy in adults with Marfan syndrome: study protocol of the multi-center randomized controlled COMPARE trial</title>
            <link>http://www.medworm.com/index.php?rid=3161345&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F3</link>
            <description>DiscussionThe COMPARE study will provide important evidence of effects of losartan treatment in adult Marfan patient population. We expect losartan to significantly reduce the occurrence and progression of aortic dilatation. This trial investigates a wide spectrum of clinical, genetic and biochemical effects of losartan aiming to provide further insight in the pathogenesis and treatment of Marfan syndrome.Trial registrationNetherlands Trial Register NTR1423. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3161345</comments>
            <pubDate>Tue, 12 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3161345</guid>        </item>
        <item>
            <title>Questionnaires in clinical trials: guidelines for optimal design and administration</title>
            <link>http://www.medworm.com/index.php?rid=3158570&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F2</link>
            <description>A good questionnaire design for a clinical trial will minimise bias and maximise precision in the estimates of treatment effect within budget. Attempts to collect more data than will be analysed may risk reducing recruitment (reducing power) and increasing losses to follow-up (possibly introducing bias). The mode of administration can also impact on the cost, quality and completeness of data collected. There is good evidence for design features that improve data completeness but further research is required to evaluate strategies in clinical trials. Theory-based guidelines for style, appearance, and layout of self-administered questionnaires have been proposed but require evaluation. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3158570</comments>
            <pubDate>Mon, 11 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3158570</guid>        </item>
        <item>
            <title>A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: Design and statistical methods of the PERSEUS clinical program</title>
            <link>http://www.medworm.com/index.php?rid=3150918&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F11%2F1%2F1</link>
            <description>Background:
Paclitaxel-eluting stents decrease angiographic and clinical restenosis following percutaneous coronary intervention compared to bare metal stents. TAXUS Element is a third-generation paclitaxel-eluting stent which incorporates a novel, thinner-strut, platinum-enriched metal alloy platform. The stent is intended to have enhanced radiopacity and improved deliverability compared to other paclitaxel-eluting stents. The safety and efficacy of the TAXUS Element stent are being evaluated in the pivotal PERSEUS clinical trials.
Methods:
The PERSEUS trials include two parallel studies of the TAXUS Element stent in single, de novo coronary atherosclerotic lesions. The PERSEUS Workhorse study is a prospective, randomized (3:1), single-blind, non-inferiority trial in subjects with lesion ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3150918</comments>
            <pubDate>Thu, 07 Jan 2010 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3150918</guid>        </item>
        <item>
            <title>Study on the evaluation of the clinical effects of traditional chinese medicine in heart failure by complex intervention: protocol of SECETCM-HF</title>
            <link>http://www.medworm.com/index.php?rid=3116967&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F122</link>
            <description>The objective is to establish the evaluation index system for the integration of TCM and western medicine. The evaluation indexes which include TCM items will specify the research design and methods.MethodNine medical centers in different cities in China will participate in the trial. A population of 340 patients with HF will be enrolled through a central randomized system for different test groups. Group A will be treated with only western medicine, while group B with western and Chinese medicine together. The study will last for 12 months from the date of enrollment. The cardiovascular death will be the primary outcome.DiscussionBy putting the protocol into practice, the clinical effects of TCM for HF will be identified scientifically, objectively as well as rationally. The proper index ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3116967</comments>
            <pubDate>Thu, 24 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3116967</guid>        </item>
        <item>
            <title>Screening asymptomatic patients with diabetes for unknown coronary artery disease: Does it reduce risk? An open-label randomized trial comparing a strategy based on exercise testing aimed at revascularization with management based on pharmacological/behavioural treatment of traditional risk factors

DADDY-D Trial (Does coronary Atherosclerosis Deserve to be Diagnosed andtreated earlY in Diabetics?)</title>
            <link>http://www.medworm.com/index.php?rid=3116970&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F119</link>
            <description>The objective of the study is to evaluate the efficacy of the screening strategy aimed at revascularization. A cost-effectiveness analysis will be performed at the end of the follow up.DiscussionThe study will provide useful information about prevention and treatment of diabetic patients at high risk of coronary events. It will be made clearer if detection of silent coronary artery disease has to be recommended and followed by treatment. Given the simplicity of the study protocol, it will be easily transferable to the real world.Trial registration: (ClinicalTrials.gov): NCT00547872 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3116970</comments>
            <pubDate>Wed, 23 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3116970</guid>        </item>
        <item>
            <title>Rationale and design of WEBCARE: A randomized, controlled, web-based behavioral intervention trial in cardioverter-defibrillator patients to reduce anxiety and device concerns and enhance quality of life</title>
            <link>http://www.medworm.com/index.php?rid=3116969&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F120</link>
            <description>We present the rationale and study design of the WEB-based distress management program for implantable CARdioverter dEfibrillator patients (WEBCARE) trial.
Methods:
WEBCARE is a multi-center, multi-disciplinary, randomized, controlled behavioral intervention trial designed to examine the effectiveness of a web-based approach in terms of reducing levels of anxiety and device concerns and enhancing QoL. Consecutive patients hospitalized for the implantation of an ICD will be approached for study participation while in hospital and randomized to the intervention arm (n = 175) versus usual care (n = 175) at baseline (5-10 days post implantation). Patients will complete assessments of patient-centered outcomes at baseline, 14, 26, and 52 weeks after implantation. Patients randomized to the inte...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3116969</comments>
            <pubDate>Wed, 23 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3116969</guid>        </item>
        <item>
            <title>The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone</title>
            <link>http://www.medworm.com/index.php?rid=3116968&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F121</link>
            <description>Background:
The standard of care for metastatic gastric cancer (MGC) is systemic chemotherapy which leads to a median survival of 6-15 months. Survival beyond 3 years is rare. For selected groups of patients with limited MGC, retrospective studies have shown improved overall survival following gastrectomy and metastasectomies including peritoneal stripping with continuous hyperthermic peritoneal perfusion (CHPP), liver resection, and pulmonary resection. Median survival after liver resection for MGC is up to 34 months, with a five year survival rate of 24.5%. Similarly, reported median survival after pulmonary resection of MGC is 21 months with long term survival of greater than 5 years a possibility. Several case reports and small studies have documented evidence of long-term survival in ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3116968</comments>
            <pubDate>Wed, 23 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3116968</guid>        </item>
        <item>
            <title>Effectiveness of adjuvant radiotherapy in patients with oropharyngeal and floor of mouth squamous cell carcinoma and concomitant histological verification of singular ipsilateral cervical lymph node metastasis (pN1-state) -A prospective multicenter randomized controlled clinical trial using a comprehensive cohort design-</title>
            <link>http://www.medworm.com/index.php?rid=3112964&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F118</link>
            <description>Conclusion:
The inherent challenges of a rare clinical condition (pN1) and two substantially different therapy arms would limit the practicality of a classical randomized study. The concept of a Comprehensive Cohort Design combines the preference of a randomized study, with the option of careful data interpretation within an observational study.Trial registration: ClinicalTrials.gov: NCT00964977 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3112964</comments>
            <pubDate>Wed, 23 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3112964</guid>        </item>
        <item>
            <title>Association of trial registration with the results and conclusions of published trials of new oncology drugs</title>
            <link>http://www.medworm.com/index.php?rid=3094265&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F116</link>
            <description>Conclusions:
Trial registration alone, without a requirement for full reporting of research results, does not appear to reduce a bias toward results and conclusions favoring new drugs in the clinical trials literature. Our findings support the inclusion of full results reporting in trial registers, as well as protocols to allow assessment of whether results have been completely reported. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3094265</comments>
            <pubDate>Wed, 16 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3094265</guid>        </item>
        <item>
            <title>SWiss Atorvastatin and Interferon Beta-1b Trial In Multiple Sclerosis (SWABIMS) - rationale, design and methodology</title>
            <link>http://www.medworm.com/index.php?rid=3086784&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F115</link>
            <description>DiscussionSWABIMS is designed to give further information about the therapeutic effect of atorvastatin 40mg per os daily as add-on therapy to interferon beta-1b in patients with relapsing-remitting multiple sclerosis. Furthermore important safety and tolerability data will be generated.Trial Registration: http://www.clinicaltrials.gov. Identifier: NCT00942591; Swissmedic reference number: 2005DR2119 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3086784</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3086784</guid>        </item>
        <item>
            <title>The PACE Study: A randomised clinical trial of cognitive activity (CA) for older adults with mild cognitive impairment (MCI)</title>
            <link>http://www.medworm.com/index.php?rid=3083651&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F114</link>
            <description>DiscussionThe proposed project will produce the best available evidence on the merits of increased cognitive activity as a strategy to prevent cognitive decline among older adults with MCI. We anticipate that the results of this study will have implications for the development of evidence-based preventive strategies to reduce the rate of cognitive decline amongst older people at risk of dementia.Trial registration: ACTRN12608000556347 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3083651</comments>
            <pubDate>Mon, 14 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3083651</guid>        </item>
        <item>
            <title>Protocol for the Osteoporosis Choice trial.  A pilot randomized trial of a decision aid in primary care practice</title>
            <link>http://www.medworm.com/index.php?rid=3077369&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F113</link>
            <description>Background:
Bisphosphonates can reduce fracture risk in patients with osteoporosis, but many at-risk patients do not start or adhere to these medications. The aims of this study are to: (1) preliminarily evaluate the effect of an individualized 10-year osteoporotic fracture risk calculator and decision aid (OSTEOPOROSIS CHOICE) for postmenopausal women at risk for osteoporotic fractures; and (2) assess the feasibility and validity (i.e., absence of contamination) of patient-level randomization (vs. cluster randomization) in pilot trials of decision aid efficacy.
Methods:
This is a protocol for a parallel, 2-arm, randomized trial to compare an intervention group receiving OSTEOPOROSIS CHOICE to a control group receiving usual primary care. Postmenopausal women with bone mineral density T-sc...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3077369</comments>
            <pubDate>Thu, 10 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3077369</guid>        </item>
        <item>
            <title>Acupuncture for dry eye: a randomised controlled trial protocol</title>
            <link>http://www.medworm.com/index.php?rid=3054421&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F112</link>
            <description>DiscussionThe results of this trial will be used as a basis for clarifying the efficacy of acupuncture for dry eye.Trial registration: ClinicalTrials.gov NCT00969280. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3054421</comments>
            <pubDate>Thu, 03 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3054421</guid>        </item>
        <item>
            <title>The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=3050090&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F109</link>
            <description>Conclusions:
This trial did not reach the planned sample size of 400 patients and consequently, the study power to detect an increase in the risk of serious adverse events was reduced. This trial provides no reliable evidence of benefit or harm and a larger trial would be needed to establish safety and effectiveness.This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN23625128. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3050090</comments>
            <pubDate>Thu, 03 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3050090</guid>        </item>
        <item>
            <title>Response to: The BRAIN TRIAL: a randomised, placebo controlled tr ial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury</title>
            <link>http://www.medworm.com/index.php?rid=3050089&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F110</link>
            <description>A response to and comment on The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Haleema Shakur, Ian Roberts, et al. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3050089</comments>
            <pubDate>Thu, 03 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3050089</guid>        </item>
        <item>
            <title>Response to: The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury - authors' reply</title>
            <link>http://www.medworm.com/index.php?rid=3050088&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F111</link>
            <description>A response to the letter regarding The BRAIN TRIAL: a randomized, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury, by Mr Vincent Simmon President and CEO of Xytis Inc. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3050088</comments>
            <pubDate>Thu, 03 Dec 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3050088</guid>        </item>
        <item>
            <title>When worlds collide</title>
            <link>http://www.medworm.com/index.php?rid=3035167&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F108</link>
            <description>The UK has a strong tradition of innovative evaluative health care research. There are, however, considerable forces impeding collaboration between clinicians, academics, patients and their advocates and industry. This paper argues that, if the UK is to regain a position at the forefront of clinical research into evaluation of care, some of these forces need to be overcome. Now, with explicit encouragement from funders within the UK's NHS, it is urgent that all parties discover better ways of working together so that more broad and meaningful research can be produced in a timely fashion. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3035167</comments>
            <pubDate>Fri, 27 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3035167</guid>        </item>
        <item>
            <title>Does point of care prothrombin time measurement reduce the transfusion of fresh frozen plasma in patients undergoing major surgery? The POC-OP randomized-controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=3017906&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F107</link>
            <description>The objective of the POC-OP trial is to determine the effectiveness of point of care prothrombin time testing to reduce the administration of FFP. It is a patient and assessor blind, single center randomized controlled parallel group trial in 220 patients aged between 18 and 90 years undergoing major surgery (any type, except cardiac surgery and liver transplantation) with an estimated blood loss during surgery exceeding 20% of the calculated total blood volume or a requirement of FFP according to the judgment of the physicians in charge. Patients are randomized to usual care plus point of care prothrombin time testing or usual care alone without point of care testing. The primary outcome is the relative risk to receive any FFP perioperatively. The inclusion of 110 patients per group will ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3017906</comments>
            <pubDate>Mon, 23 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3017906</guid>        </item>
        <item>
            <title>The Toronto prehospital hypertonic resuscitation-head injury and multi organ dysfunction trial (TOPHR HIT) - Methods and data collection tools</title>
            <link>http://www.medworm.com/index.php?rid=3014095&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F105</link>
            <description>We describe a feasibility study of randomizing head injured patients to hypertonic saline and dextran vs. normal saline administration in the out of hospital setting.
Methods:
This feasibility study employs a randomized, placebo-controlled design evaluating normal saline compared with a single dose of 250 ml of 7.5% hypertonic saline in 6% dextran 70 in the management of traumatic brain injuries. The primary feasibility endpoints of the trial were: 1) baseline survival rates for the treatment and control group to aid in the design of a definitive multicentre trial, 2) randomization compliance rate, 3) ease of protocol implementation in the out-of-hospital setting, and 4) adverse event rate of HSD infusion.The secondary objectives include measuring the effect of HSD in modulating the immuno...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3014095</comments>
            <pubDate>Fri, 20 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3014095</guid>        </item>
        <item>
            <title>Cost-effectiveness of postural exercise therapy versus physiotherapy in computer screen-workers with early non-specific work-related upper limb disorders (WRULD); a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=3001724&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F103</link>
            <description>Conclusions:
Although our trial failed to find significant differences in VAS, QALYs and ICERs based on VAS and QALYs at one-year follow-up, CEACs suggest that postural exercise therapy according to Mensendieck / Cesar has a higher probability of being cost-effective compared to regular physiotherapy; however further research is required.Trial registration: ISRCTN 15872455 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3001724</comments>
            <pubDate>Tue, 17 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3001724</guid>        </item>
        <item>
            <title>Clinical trial to assess the effect of physical exercise on endothelial function and insulin resistance in pregnant women</title>
            <link>http://www.medworm.com/index.php?rid=3001723&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F104</link>
            <description>Background:
Preeclampsia (PE) is a common maternal disease that complicates 5 to 10% of pregnancies and remains as the major cause of maternal and neonatal mortality. Cost-effective interventions aimed at preventing the development of preeclampsia are urgently needed. However, the pathogenesis of PE is not well known. Multiple mechanisms such as oxidative stress, endothelial dysfunction and insulin resistance may contribute to its development. Regular aerobic exercise recovers endothelial function; improves insulin resistance and decreases oxidative stress. Therefore the purpose of this clinical trial is to determine the effect of regular aerobic exercise on endothelial function, on insulin resistance and on pregnancy outcome.Methods and design: 64 pregnant women will be included in a blin...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3001723</comments>
            <pubDate>Tue, 17 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3001723</guid>        </item>
        <item>
            <title>Subgroup Analysis of Trials Is Rarely Easy (SATIRE): a study protocol for a systematic review to characterize the analysis, reporting, and claim of subgroup effects in randomized trials</title>
            <link>http://www.medworm.com/index.php?rid=2975267&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F101</link>
            <description>The objectives of this study are: 1) to describe the reporting of subgroup analyses and claims of subgroup effects in randomized controlled trials, 2) to assess study characteristics associated with reporting of subgroup analyses and with claims of subgroup effects, and 3) to examine the analysis, and interpretation of subgroup effects for each study's primary outcome.
Methods:
We will conduct a systematic review of 464 randomized controlled human trials published in 2007 in the 118 Core Clinical Journals defined by the National Library of Medicine. We will randomly select journal articles, stratified in a 1:1 ratio by higher impact versus lower impact journals. According to 2007 ISI total citations, we consider the New England Journal of Medicine, JAMA, Lancet, Annals of Internal Medicine...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2975267</comments>
            <pubDate>Mon, 09 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2975267</guid>        </item>
        <item>
            <title>The impact of networks on clinical trials in the United Kingdom</title>
            <link>http://www.medworm.com/index.php?rid=2979237&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F100</link>
            <description>The conduct of clinical trials in the UK has been affected by the recent introduction of managed clinical networks, clinical research networks and rigorous governance regulations. This commentary considers the challenges that these changes have posed for clinical triallists in the UK, based on experiences derived in the conduct of a multicentre neonatal clinical trial under the conditions that now prevail. We conclude that the considerable skills and knowledge that are now required to be an effective Principal Investigator should be recognised and that application processes, including issuing honorary contracts, should be simplified and centralised. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2979237</comments>
            <pubDate>Wed, 04 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2979237</guid>        </item>
        <item>
            <title>The impact of networks on clinical trials in the United Kingdomom</title>
            <link>http://www.medworm.com/index.php?rid=2965255&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com</link>
            <description>The conduct of clinical trials in the UK has been affected by the recent introduction of managed clinical networks, clinical research networks and rigorous governance regulations. This commentary considers the challenges that these changes have posed for clinical triallists in the UK, based on experiences derived in the conduct of a multicentre neonatal clinical trial under the conditions that now prevail. We conclude that the considerable skills and knowledge that are now required to be an effective Principal Investigator should be recognised and that application processes, including issuing honorary contracts, should be simplified and centralised. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2965255</comments>
            <pubDate>Wed, 04 Nov 2009 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">2965255</guid>        </item>
        <item>
            <title>Efficacies of the new Paclitaxel-eluting Coroflex PleaseTM Stent in percutaneous coronary intervention; comparison of efficacy between Coroflex PleaseTM and TaxusTM (ECO-PLEASANT) trial: study rationale and design</title>
            <link>http://www.medworm.com/index.php?rid=2918090&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F98</link>
            <description>DiscussionThe ECO-PLEASANT trial is the study not yet performed to directly compare the efficacy and safety of the Coroflex PleaseTM versus Taxus LiberteTM stent. On the basis of this trial, we will be able to find out whether the Coroflex PleaseTM stent is non-inferior to Taxus LiberteTM stent or not.Trial registration: ClinicalTrials.gov number, NCT00699543. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2918090</comments>
            <pubDate>Thu, 22 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2918090</guid>        </item>
        <item>
            <title>Effectiveness of focused structural massage and relaxation massage for chronic low back pain: protocol for a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2910379&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F96</link>
            <description>Conclusion:
Results of this trial will help clarify the value of two types of massage therapy for chronic low back pain.Trial registration: Clinical Trials.gov NCT 00371384. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2910379</comments>
            <pubDate>Mon, 19 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2910379</guid>        </item>
        <item>
            <title>Common definition for categories of clinical research:
a prerequisite for a survey on regulatory requirements
by the European Clinical Research Infrastructures 
Network (ECRIN)</title>
            <link>http://www.medworm.com/index.php?rid=2896607&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F95</link>
            <description>Conclusion:
The list of clinical research categories as used for the survey could serve as a contribution to the, much needed, task of harmonisation and simplification of the regulatory requirements for clinical research in Europe. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2896607</comments>
            <pubDate>Thu, 15 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2896607</guid>        </item>
        <item>
            <title>IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy - a randomised controlled trial in an interdisciplinary setting</title>
            <link>http://www.medworm.com/index.php?rid=2906562&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F94</link>
            <description>DiscussionThis is a randomised controlled patient and observer blinded two-group parallel trial designed to assess efficacy and safety of infrahepatic IVC clamping during elective hepatectomy.Trial registration: ClinicalTrials NCT00732979 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2906562</comments>
            <pubDate>Mon, 12 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2906562</guid>        </item>
        <item>
            <title>IVC CLAMP: infrahepatic inferior vena cava clamping during hepatectomy - a randomised controlled trial in an interdisclipinary setting</title>
            <link>http://www.medworm.com/index.php?rid=2888408&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F94</link>
            <description>DiscussionThis is a randomised controlled patient and observer blinded two-group parallel trial designed to assess efficacy and safety of infrahepatic IVC clamping during elective hepatectomy.Trial registration: ClinicalTrials NCT00732979 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2888408</comments>
            <pubDate>Mon, 12 Oct 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2888408</guid>        </item>
        <item>
            <title>A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: &quot;COBBANA&quot; trial</title>
            <link>http://www.medworm.com/index.php?rid=2840423&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F91</link>
            <description>DiscussionThe COBBANA trial aims to assess, whether the haemostatic effect of Lyostypt is superior to Surgicel in suture hole bleedings of arterial bypass anastomoses.Trial registrationNCT00837954 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2840423</comments>
            <pubDate>Mon, 28 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2840423</guid>        </item>
        <item>
            <title>Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration</title>
            <link>http://www.medworm.com/index.php?rid=2837342&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F90</link>
            <description>This study has been designed to investigate whether intracoronary bolus administration of abciximab is more effective than intravenous bolus administration in improving myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration.
Methods:
The Comparison of IntraCoronary versus intravenous abciximab administration during Emergency Reperfusion Of ST-segment elevation myocardial infarction (CICERO) trial is a single-center, prospective, randomized open-label trial with blinded evaluation of endpoints. A total of 530 patients with STEMI undergoing primary percutaneous coronary intervention are randomly assigned to either an intracoronary or intravenous bolus of weight-adjusted abciximab. The pri...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2837342</comments>
            <pubDate>Sun, 27 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2837342</guid>        </item>
        <item>
            <title>The Tilburg double blind randomised controlled trial comparing inguinal hernia repair according to Lichtenstein and the transinguinal preperitoneal technique</title>
            <link>http://www.medworm.com/index.php?rid=2830037&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F89</link>
            <description>Background:
Anterior open treatment of the inguinal hernia with a tension free mesh has reduced the incidence of recurrence and direct postoperative pain. The Lichtenstein procedure rules nowadays as reference technique for hernia treatment. Not recurrences but chronic pain is the main postoperative complication in inguinal hernia repair after Lichtenstein's technique. Preliminary experiences with a soft mesh placed in the preperitoneal space showed good results and less chronic pain.MethodSThe TULIP is a double-blind randomised controlled trial in which 300 patients will be randomly allocated to anterior inguinal hernia repair according to Lichtenstein or the transinguinal preperitoneal technique with soft mesh. All unilateral primary inguinal hernia patients eligible for operation who me...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2830037</comments>
            <pubDate>Thu, 24 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2830037</guid>        </item>
        <item>
            <title>The Irish DAFNE Study Protocol: A cluster randomised trial of group versus individual follow-up after structured education for Type 1 diabetes</title>
            <link>http://www.medworm.com/index.php?rid=2826297&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F88</link>
            <description>DiscussionThis pragmatic clinical trial evaluating group follow-up after a structured education programme has been designed to have broad generalisability. The results should inform how best to manage the well educated patient with Type 1 diabetes in the real world of clinical practiceTrial registration: Current Controlled Trials ISRCTN79759174 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2826297</comments>
            <pubDate>Tue, 22 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2826297</guid>        </item>
        <item>
            <title>The HAART cell phone adherence trial (WelTel Kenya1): a randomized controlled trial protocol</title>
            <link>http://www.medworm.com/index.php?rid=2816683&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F87</link>
            <description>This study protocol tests whether a novel structured mobile phone intervention can positively contribute to ART management in a resource-limited setting.Trial Registration Number: NCT00830622 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2816683</comments>
            <pubDate>Mon, 21 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2816683</guid>        </item>
        <item>
            <title>QUARITE (quality of care, risk management and technology in obstetrics): a cluster-randomized trial of a multifaceted intervention to improve emergency obstetric care in Senegal and Mali</title>
            <link>http://www.medworm.com/index.php?rid=2805893&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F85</link>
            <description>The objective of this trial is to evaluate the effectiveness of the ALARM International Program (AIP) in reducing maternal mortality in referral hospitals in Senegal and Mali. Secondary goals include evaluation of the relationships between effectiveness and resource availability, service organization, medical practices, and satisfaction among health personnel.
Methods:
This is an international, multi-centre, controlled cluster-randomized trial of a complex intervention. The intervention is based on the concept of evidence-based practice and on a combination of two approaches aimed at improving the performance of health personnel: 1) Educational outreach visits; and 2) the implementation of facility-based maternal death reviews.The unit of intervention is the public health facility equipped...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2805893</comments>
            <pubDate>Thu, 17 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2805893</guid>        </item>
        <item>
            <title>Structured information during the ICU stay to reduce anxiety: study protocol of a multicenter randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2791743&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F84</link>
            <description>DiscussionIn contrast to former trials on information programs on the ICU-stay our intervention will take place in the ICU itself. This approach will ensure to compensate for memory effects due to anesthesia or preoperative stress. Further the results will be applicable to non-elective ICU-patients.Trial RegistrationClinicalTrials NCT00764933 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2791743</comments>
            <pubDate>Sun, 13 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2791743</guid>        </item>
        <item>
            <title>REFINE (Reducing Falls in In-Patient Elderly) - a randomised controlled trial.</title>
            <link>http://www.medworm.com/index.php?rid=2780215&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F83</link>
            <description>DiscussionThe REFINE study is the first randomised controlled trial of bedside pressure sensors in elderly inpatients in an acute NHS Trust. We will assess whether falls can be successfully and cost effectively reduced using this technology, and report on its acceptability to both patients and staff.ISRCTN trial number : ISRCTN44972300. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2780215</comments>
            <pubDate>Wed, 09 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2780215</guid>        </item>
        <item>
            <title>Cost-minimization analysis in a blind randomized trial on small-incision versus laparoscopic cholecystectomy from a societal perspective: sick leave outweighs efforts in hospital savings</title>
            <link>http://www.medworm.com/index.php?rid=2764194&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F80</link>
            <description>Conclusions:
Based on differences in costs, small-incision cholecystectomy seems to be the preferred operative technique over the laparoscopic technique both from a hospital and societal cost perspective. Sick leave associated with convalescence after cholecystectomy in employed patients results in considerable costs to society.Trial registration ISRCTN Register, number ISRCTN67485658. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2764194</comments>
            <pubDate>Thu, 03 Sep 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2764194</guid>        </item>
        <item>
            <title>Performance-based readability testing of participant information for a Phase 3 IVF trial</title>
            <link>http://www.medworm.com/index.php?rid=2754794&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F79</link>
            <description>Conclusions:
The original participant information sheet may not have enabled patients fully to give valid consent. Participants seeing the revised sheet were better able to understand the trial. Those who write information for trial participants should take account of good practice in information design. Performance-based User Testing may be a useful method to indicate strengths and weaknesses in trial information. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2754794</comments>
            <pubDate>Mon, 31 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2754794</guid>        </item>
        <item>
            <title>Psychoeducation versus treatment as usual in diabetic patients with subthreshold depression: preliminary results of a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2732106&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F78</link>
            <description>Conclusion:
Psycho-educational treatment appears to be beneficial in diabetic patients with mild to moderate depressive symptoms, but its effects are comparable with the non-specific support given to the subjects in the control group.Trial registration: Current Controlled Trials ISRCTN58745372 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2732106</comments>
            <pubDate>Tue, 25 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2732106</guid>        </item>
        <item>
            <title>The efficacy of surgical decompression before 24 hours versus 24 to 72 hours in patients with spinal cord injury from T1 to L1 - with specific consideration on ethics:  a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2726181&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F77</link>
            <description>This study will hopefully assist in contributing to the question of the efficacy of the timing of surgery in traumatic thoracolumbar SCI.RCT registration number: ISRCTN61263382 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2726181</comments>
            <pubDate>Sun, 23 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2726181</guid>        </item>
        <item>
            <title>Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2723732&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F75</link>
            <description>DiscussionThe important features of this trial include the randomization procedures (controlled by a central randomization system), a standardized protocol of acupuncture manipulation, and the fact that this is the first multicenter randomized trial of FD and acupuncture to be performed in China. The results of this trial will determine whether acupuncture is an effective treatment for FD and whether using different acupoints or different meridians leads to differences in clinical efficacy.Trial registration number: Clinical Trials.gov Identifier: NCT00599677. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2723732</comments>
            <pubDate>Sat, 22 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2723732</guid>        </item>
        <item>
            <title>Barriers encountered during enrollment in an internet-mediated randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2723731&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F76</link>
            <description>Conclusions:
Prospective participants in an online clinical trial encountered a number of barriers to enrollment that led them to request help from study staff. Questions about the complex enrollment process itself were common. In a complex multi-step enrollment process, providing personalized feedback to potential participants indicating their status within the enrollment process may be beneficial.Trial Registration: ClinicalTrials.gov NCT00729040 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2723731</comments>
            <pubDate>Sat, 22 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2723731</guid>        </item>
        <item>
            <title>Efficacy and safety of bilateral continuous theta burst stimulation (cTBS) for the treatment of chronic tinnitus: design of a three-armed randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2717998&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F74</link>
            <description>Background:
Tinnitus, the perception of sound and noise in absence of an auditory stimulus, has been shown to be associated with maladaptive neuronal reorganization and increased activity of the temporoparietal cortex. Transient modulation of tinnitus by repetitive transcranial magnetic stimulation (rTMS) indicated that this area is critically involved in the pathophysiology of tinnitus and suggested new treatment strategies. However, the therapeutic efficacy of rTMS in tinnitus is still unclear, individual response is variable, and the optimal stimulation area disputable. Recently, continuous Theta burst stimulation (cTBS) has been put forward as an effective rTMS protocol for the reduction of pathologically enhanced cortical excitability.
Methods:
48 patients with chronic subjective tinn...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2717998</comments>
            <pubDate>Thu, 20 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2717998</guid>        </item>
        <item>
            <title>A phase II clinical trial to assess the safety of clonidine in acute organophosphorus pesticide poisoning</title>
            <link>http://www.medworm.com/index.php?rid=2714222&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F73</link>
            <description>Conclusions:
Our findings suggest use of moderate doses of clonidine in acute organophosphate poisoning can be used without causing frequent clinical problems but that higher doses are associated with a high incidence of hypotension requiring intervention. Further studies are needed to study the efficacy of clonidine as an antidote in organophosphate poisoning.Trial registration: Current Controlled Trial ISRCTN89917816. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2714222</comments>
            <pubDate>Wed, 19 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2714222</guid>        </item>
        <item>
            <title>Protocol for a randomized controlled trial on risk adapted damage control orthopedic surgery of femur shaft fractures in multiple trauma patients</title>
            <link>http://www.medworm.com/index.php?rid=2714223&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F72</link>
            <description>This study will help to answer the question whether the &quot;early total care&quot; or the damage control&quot; concept is associated with better outcome.Trial registration: Current Controlled Trials ISRCTN10321620 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2714223</comments>
            <pubDate>Tue, 18 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2714223</guid>        </item>
        <item>
            <title>Rapid reduction versus abrupt quitting for smokers who want to stop soon: a randomised controlled non-inferiority trial</title>
            <link>http://www.medworm.com/index.php?rid=2701070&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F69</link>
            <description>Background:
The standard way to stop smoking is to stop abruptly on a quit day with no prior reduction in consumption of cigarettes. Many smokers feel that reduction is natural and if reduction programmes were offered, many more might take up treatment. Few trials of reduction versus abrupt cessation have been completed. Most are small, do not use pharmacotherapy, and do not meet the standards necessary to obtain a marketing authorisation for a pharmacotherapy.Design/MethodsWe will conduct a non-inferiority randomised trial of rapid reduction versus standard abrupt cessation among smokers who want to stop smoking. In the reduction arm, participants will be advised to reduce smoking consumption by half in the first week and to 25% of baseline in the second, leading up to a quit day at which...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2701070</comments>
            <pubDate>Thu, 13 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2701070</guid>        </item>
        <item>
            <title>Efficacy of prescribed injectable diacetylmorphine in the Andalusian trial: Bayesian analysis of responders and non-responders according to a multi domain outcome index</title>
            <link>http://www.medworm.com/index.php?rid=2701069&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F70</link>
            <description>Conclusion:
The present analysis suggests a clinical superiority of injectable diacetylmorphine compared to oral methadone in the treatment of severely affected heroin injectors not benefiting sufficiently from the available treatments.Trial Registration: Current Controlled Trials ISRCTN52023186 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2701069</comments>
            <pubDate>Thu, 13 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2701069</guid>        </item>
        <item>
            <title>Promoting smoking cessation in Bangladeshi and Pakistani male adults: design of a pilot cluster randomised controlled trial of trained community smoking cessation workers</title>
            <link>http://www.medworm.com/index.php?rid=2701068&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F71</link>
            <description>This study aims to tackle some of the main barriers to use of stop smoking services and adherence to treatment programmes by redesigning service delivery to be more acceptable to these adult male populations. The study compares the effectiveness of trained Pakistani and Bangladeshi smoking cessation workers operating in an outreach capacity ('clinic + outreach') with standard care ('clinic only') to improve access to and success of National Health Service smoking cessation services.
Methods:
This is a pilot cluster randomised controlled trial based in Birmingham, UK. Super output areas of Birmingham will be identified in which more than 10% of the population are of Pakistani and/or Bangladeshi origin. From these areas, 'natural geographical communities' will be identified. Sixteen aggregat...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2701068</comments>
            <pubDate>Thu, 13 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2701068</guid>        </item>
        <item>
            <title>Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2697668&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F68</link>
            <description>Conclusions:
The intervention did not change the primary outcome or most secondary outcomes. Recruitment targets were not achieved and the under-recruitment of practices and patients alongside a selection bias of participating GPs, prohibit definite conclusions, but the CI indicates a non-effectiveness of the intervention in this sample. We describe the lessons learned from conducting the trial for the future planning and conduct of confirmatory trials in primary care.Trial registration number: ISRCTN08601529. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2697668</comments>
            <pubDate>Wed, 12 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2697668</guid>        </item>
        <item>
            <title>Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial</title>
            <link>http://www.medworm.com/index.php?rid=2689992&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F67</link>
            <description>Conclusion:
The findings from this small scale quasi-randomised trial showed that exercise therapy was effective in improving activities of daily living and perceived health status in patients with Parkinson's disease. Indeed, exercise therapy could be offered to patients with Parkinson disease, considering that it is low in cost and usually has no negative side effects.Trial registration: Current Controlled Trials ISRCTN98825027 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2689992</comments>
            <pubDate>Mon, 10 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2689992</guid>        </item>
        <item>
            <title>Periodontal treatment to improve glycaemic control in diabetic patients: study protocol of the randomized, controlled DIAPERIO trial</title>
            <link>http://www.medworm.com/index.php?rid=2661651&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F65</link>
            <description>DiscussionThe DIAPERIO trial will provide insight into the question of whether periodontal treatment could lead to an improvement in glycaemic control in metabolically unbalanced diabetic patients suffering from periodontitis. The results of this trial will help to provide evidence-based recommendations for clinicians and a draft framework for designing national health policies.Trial registrationCurrent Controlled Trials ISRCTN15334496 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2661651</comments>
            <pubDate>Sat, 01 Aug 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2661651</guid>        </item>
        <item>
            <title>Evaluation of an online Diabetes Needs Assessment Tool (DNAT) for health professionals: a randomised controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2655423&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F63</link>
            <description>Background:
Continuous medical education is traditionally reliant to a large extent on self-directed learning based on individuals' perceived learning priorities. Evidence suggests that this ability to self-assess is limited, and more so in the least competent. Therefore, it may be of benefit to utilise some form of external assessment for this purpose. Many diabetes educational programmes have been introduced, but few have been assessed for their benefit in a systematic manner. As diabetes is an increasingly prevalent disease, methods for the dissemination and understanding of clinical guidelines need to be explored for their effectiveness. This paper describes the study design of a randomised controlled trial to evaluate the effectiveness of using an interactive online Diabetes Needs Ass...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655423</comments>
            <pubDate>Wed, 29 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655423</guid>        </item>
        <item>
            <title>Reminiscence groups for people with dementia and their family carers: pragmatic eight-centre randomised trial of joint reminiscence and maintenance versus usual treatment: a protocol</title>
            <link>http://www.medworm.com/index.php?rid=2655422&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F64</link>
            <description>DiscussionOur Cochrane review (2005) on reminiscence therapy for people with dementia did not identify any rigorous trials or economic analyses in this field.Trial Registration: ISRCTN42430123 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2655422</comments>
            <pubDate>Wed, 29 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2655422</guid>        </item>
        <item>
            <title>Clinical evaluation of magnetic resonance imaging in coronary heart disease: The CE-MARC study</title>
            <link>http://www.medworm.com/index.php?rid=2647190&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F62</link>
            <description>DiscussionThe CE-MARC study is a prospective, diagnostic accuracy cohort study of 750 patients assessing the performance of a multi-parametric CMR study in detecting CHD using invasive X-ray coronary angiography as the reference standard and comparing it with ETT and SPECT.Trial Registration: 	Current Controlled Trials ISRCTN77246133 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2647190</comments>
            <pubDate>Tue, 28 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2647190</guid>        </item>
        <item>
            <title>Ethical and policy issues in cluster randomized trials: rationale and design of a mixed methods research study</title>
            <link>http://www.medworm.com/index.php?rid=2647191&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F61</link>
            <description>Background:
Cluster randomized trials are an increasingly important methodological tool in health research. In cluster randomized trials, intact social units or groups of individuals, such as medical practices, schools, or entire communities -- rather than individual themselves -- are randomly allocated to intervention or control conditions, while outcomes are then observed on individual cluster members. The substantial methodological differences between cluster randomized trials and conventional randomized trials pose serious challenges to the current conceptual framework for research ethics. The ethical implications of randomizing groups rather than individuals are not addressed in current research ethics guidelines, nor have they even been thoroughly explored. The main objectives of thi...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2647191</comments>
            <pubDate>Mon, 27 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2647191</guid>        </item>
        <item>
            <title>RADAR - A randomised, multi-centre, prospective study comparing best medical treatment versus best medical treatment plus renal artery stenting in patients with haemodynamically relevant atherosclerotic renal artery stenosis</title>
            <link>http://www.medworm.com/index.php?rid=2643112&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F60</link>
            <description>Background:
Prospective, international, multi-centre, randomised (1:1) trial to evaluate the clinical impact of percutaneous transluminal renal artery stenting (PTRAS) on the impaired renal function measured by the estimated glomerular filtration rate (eGFR) in patients with haemodynamically significant atherosclerotic renal artery stenosis.
Methods:
Patients will be randomised to receive either PTRAS using the Dynamic Renal Stent system plus best medical treatment or best medical treatment. Renal stenting will be performed under angiographic imaging. For patients randomised to best medical treatment the degree of stenosis measured by renal duplex sonography (RDS) will be confirmed by MR angio or multi-slice CT where possible. Best medical treatment will be initiated at randomisation or po...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2643112</comments>
            <pubDate>Sun, 26 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2643112</guid>        </item>
        <item>
            <title>Implementation of Internet-based preventive interventions for depression and anxiety: role of support? The design of a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2640885&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F59</link>
            <description>This study examines whether an internet-based self-help intervention with a coach is more effective than the same intervention without a coach in terms of clinical outcomes, drop-out and economic costs. Moreover, we will investigate which level of support by a coach is more effective compared to other levels of support.
Methods:
In this randomized controlled trial, a total of 500 subjects (18 year and older) from the general population with mild to moderate depression and/or anxiety will be assigned to one of five conditions: (1) web-based problem solving through the internet (self-examination therapy) without a coach; (2) the same as 1, but with the possibility to ask help from a coach on the initiative of the respondent (on demand, by email); (3) the same as 1, but with weekly scheduled ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2640885</comments>
            <pubDate>Sun, 26 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2640885</guid>        </item>
        <item>
            <title>Perioperative management in distal pancreatectomy: results of a survey in 23 European participating centres of the DISPACT trial and a review of literature</title>
            <link>http://www.medworm.com/index.php?rid=2640886&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F58</link>
            <description>Conclusion:
Most perioperative standards within the centres participating in the DISPACT trial are in accordance with current available evidence. The need for drainages requires further investigation.Clinical trial registration: ISRCTN 18452029 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2640886</comments>
            <pubDate>Sat, 25 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2640886</guid>        </item>
        <item>
            <title>DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT</title>
            <link>http://www.medworm.com/index.php?rid=2635937&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F57</link>
            <description>DiscussionThere is considerable debate about the clinical and cost effectiveness of anti-dementia drugs. DOMINO-AD seeks to provide clear evidence on the best treatment strategies for those managing patients at a particularly important clinical transition point.Trial registrationCurrent controlled trials ISRCTN49545035 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2635937</comments>
            <pubDate>Thu, 23 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2635937</guid>        </item>
        <item>
            <title>Compliance of clinical trial registries with the World Health Organization minimum data set: a survey</title>
            <link>http://www.medworm.com/index.php?rid=2623628&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F56</link>
            <description>Conclusions:
While the launch of the WHO minimum data set seemed to positively influence registries with better standardisation of approaches, individual registry entries are largely incomplete. Initiatives to ensure quality assurance of registries and trial data should be encouraged. Peer reviewers and editors should scrutinise clinical trial registration records to ensure consistency with WHO's core content requirements when considering trial-related publications. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2623628</comments>
            <pubDate>Tue, 21 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2623628</guid>        </item>
        <item>
            <title>Can you believe what you read in the papers?</title>
            <link>http://www.medworm.com/index.php?rid=2604051&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F55</link>
            <description>The number of reports of clinical trials grows by hundreds every week. However, this does not mean that people making decisions about health care are finding it easier to obtain reliable knowledge for these decisions. Some of the information is unreliable. Systematic reviews are helping to resolve this by bringing together the research on a topic, appraising and summarising it. But the quality of these reviews depends greatly on the quality of the studies, and this usually means the quality of their reports. If there are fundamental flaws within a study, such as the use of inappropriate 'randomisation' techniques in the context of reviews of the effects of interventions, the reviewers will not be able to fix these. Worse still, if they are not aware of underlying flaws, they might make inc...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2604051</comments>
            <pubDate>Wed, 15 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2604051</guid>        </item>
        <item>
            <title>Acupuncture for persistent allergic rhinitis: a multi-centre, randomised, controlled trial protocol</title>
            <link>http://www.medworm.com/index.php?rid=2599791&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F54</link>
            <description>This study consists of a multi-centre (two centres in Korea and two centres in China), randomised, controlled trial with three parallel arms (active acupuncture, sham acupuncture, and waitlist group). The active acupuncture and sham acupuncture groups will receive real or sham acupuncture treatment, respectively, three times per week for a total of 12 sessions over four weeks. Post-treatment follow-up will be performed a month later to complement these 12 acupuncture sessions. Participants in the waitlist group will not receive real or sham acupuncture treatments during this period but will only be required to keep recording their symptoms in a daily diary. After four weeks, the same treatment given to the active acupuncture group will be provided to the waitlist group.DiscussionThis trial...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2599791</comments>
            <pubDate>Mon, 13 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2599791</guid>        </item>
        <item>
            <title>The Leeds Evaluation of Efficacy of Detoxification Study (LEEDS) Prisons Project Study: protocol for a randomised controlled trial comparing methadone and buprenorphine for opiate detoxification</title>
            <link>http://www.medworm.com/index.php?rid=2596200&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F53</link>
            <description>This study seeks to address this paucity by evaluating the most routinely used interventions amongst drug users within UK prisons.Methods / DesignThis study uses randomised controlled trial methodology to compare the open use of buprenorphine and methadone for opiate detoxification, given in the context of routine care, within three UK prisons. Prisoners who are eligible and give informed consent will be entered into the trial. The primary outcome will be abstinence status eight days after detoxification, as determined by a urine test. Secondary outcomes will be recorded during the detoxification and then at one, three and six months post-detoxification.Trial registration: Current Controlled Trials ISRCTN58823759 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2596200</comments>
            <pubDate>Mon, 13 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2596200</guid>        </item>
        <item>
            <title>A review of reporting of participant recruitment and retention in RCTs in six major journals</title>
            <link>http://www.medworm.com/index.php?rid=2589975&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F52</link>
            <description>Conclusions:
The majority of RCTs reported the flow of participants well after randomisation, although only two-thirds included a complete flow chart and there was great variability over the definition of &quot;lost to follow up&quot;. Reporting of participant eligibility was poor, making assessments of recruitment practice and external validity difficult. Reporting of participant flow throughout RCTs could be improved by small changes to the CONSORT chart. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2589975</comments>
            <pubDate>Thu, 09 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2589975</guid>        </item>
        <item>
            <title>Effect of osteosynthesis, primary hemiarthroplasty, and non-surgical management for displaced four-part fractures of the proximal humerus in elderly: a multi-centre, randomised clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2582231&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F51</link>
            <description>Background:
Fractures of the proximal humerus are common injuries and account for 4-5 percent of all fractures, second only to hip and wrist fractures. The incidence is positively correlated with age and osteoporosis, and is likely to increase. Displaced four-part fractures are among the most severe injuries, accounting for 2-10 percent of proximal humeral fractures. The optimal intervention is disputed. Two previous randomised trials were very small and involved a noticeable risk of bias, and systematic reviews consequently conclude that there is inadequate basis for evidence-based treatment decisions.We aim to compare the effect of osteosynthesis with angle-stable plate with non-surgical management, and the effect of primary hemiarthroplasty with both osteosynthesis and non-surgical mana...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2582231</comments>
            <pubDate>Tue, 07 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2582231</guid>        </item>
        <item>
            <title>Intravenous fluid restriction after major abdominal surgery: 
a randomized blinded clinical trial.</title>
            <link>http://www.medworm.com/index.php?rid=2578494&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F50</link>
            <description>Conclusions:
Restricted postoperative IV fluid management, as performed in this trial, in patients undergoing major abdominal surgery appears harmful as it is accompanied by an increased risk of major postoperative complications and a prolonged postoperative hospital stay.Trial registration: Current Controlled Trials ISRCTN16719551 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2578494</comments>
            <pubDate>Mon, 06 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2578494</guid>        </item>
        <item>
            <title>Stopping randomized trials early for benefit: a protocol of the Study Of Trial Policy Of Interim Truncation-2 (STOPIT-2)</title>
            <link>http://www.medworm.com/index.php?rid=2574567&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F49</link>
            <description>DiscussionA better understanding of the extent to which tRCTs exaggerate treatment effects and of the factors associated with the magnitude of this bias can optimize trial design and data monitoring charters, and may aid in the interpretation of the results from trials stopped early for benefit. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2574567</comments>
            <pubDate>Sun, 05 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2574567</guid>        </item>
        <item>
            <title>Against pragmatism: on efficacy, effectiveness and the real world</title>
            <link>http://www.medworm.com/index.php?rid=2572300&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F48</link>
            <description>Explanatory and pragmatic trials represent ends of a continuum of attitudes about clinical trial design. Recent literature argues that pragmatic trials are more informative about clinical care in the real world. Although there is place for more pragmatic studies to inform clinical practice and health policy decision-making, we are concerned that it is generally under-appreciated that extrapolating the results of broadly inclusive pragmatic trials to the care of real patients may often be as problematic as extrapolating the results of narrowly focused explanatory or efficacy trials. Simplistic interpretation of pragmatic trials runs the risk of driving harmful policies. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2572300</comments>
            <pubDate>Sun, 05 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2572300</guid>        </item>
        <item>
            <title>The impact of avoiding cardiopulmonary by-pass during coronary artery bypass surgery in elderly patients: the Danish On-pump Off-pump Randomisation Study (DOORS)</title>
            <link>http://www.medworm.com/index.php?rid=2565437&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F47</link>
            <description>Background:
Coronary Artery Bypass Graft operation for ischemic heart disease provides improved quality of life and, in some patients, prolonged survival. Concern has, however, been raised about complications that may be related to the use of cardiopulmonary by-pass (CPB) and aortic cross-clamping. It has been hypothesized that when coronary artery by-pass grafting is performed without the use of CPB, the rate of serious complications is reduced.
Methods:
The trial is designed as an open, randomized, controlled, clinical trial with blinded assessment of end-points. Patients at or above 70 years of age, referred for surgical myocardial revascularisation, are included and randomised to receive coronary artery by-pass grafting either with or without the use of CPB and aortic cross-clamping. F...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2565437</comments>
            <pubDate>Fri, 03 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2565437</guid>        </item>
        <item>
            <title>Randomized trials published in some Chinese journals: how many are randomized?</title>
            <link>http://www.medworm.com/index.php?rid=2565438&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F46</link>
            <description>Conclusion:
Most reports of randomized controlled trials published in Chinese journals lacked an adequate description of randomization. Similarly, most so called 'randomized controlled trials' were not real randomized controlled trials owing toa lack of adequate understanding on the part of the authors of rigorous clinical trial design. All randomized controlled trials of pre-market drug clinical trial included in this research were authentic. Randomized controlled trials conducted by authors in high level hospitals, especially in hospitals affiliated to medical universities had a higher rate of authenticity. That so many non- randomized controlled trials were published as randomized controlled trials reflected the fact that peer review needs to be improved and a good practice guide for pe...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2565438</comments>
            <pubDate>Wed, 01 Jul 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2565438</guid>        </item>
        <item>
            <title>N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2551375&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F45</link>
            <description>Conclusion:
There was no detectable benefit for the prophylactic administration of oral NAC over an aggressive hydration protocol in patients with DM and CKD.Trial registration: NCT00808795 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2551375</comments>
            <pubDate>Sun, 28 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2551375</guid>        </item>
        <item>
            <title>Does a monetary incentive improve the response to a postal questionnaire in a randomised controlled trial? The MINT incentive study</title>
            <link>http://www.medworm.com/index.php?rid=2491624&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F44</link>
            <description>Conclusions:
Monetary incentives may be an effective way to increase the proportion of postal questionnaires returned and minimise loss to follow-up in clinical trials.Trial registration number: ISRCTN61305297 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2491624</comments>
            <pubDate>Sun, 21 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2491624</guid>        </item>
        <item>
            <title>Dealing with heterogeneity of treatment effects: is the literature up to the challenge?</title>
            <link>http://www.medworm.com/index.php?rid=2491625&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F43</link>
            <description>Background:
Some patients will experience more or less benefit from treatment than the averages reported from clinical trials; such variation in therapeutic outcome is termed heterogeneity of treatment effects (HTE). Identifying HTE is necessary to individualize treatment. The degree to which heterogeneity is sought and analyzed correctly in the general medical literature is unknown. We undertook this literature sample to track the use of HTE analyses over time, examine the appropriateness of the statistical methods used, and explore the predictors of such analyses.
Methods:
Articles were selected through a probability sample of randomized controlled trials (RCTs) published in Annals of Internal Medicine, BMJ, JAMA, The Lancet, and NEJM during odd numbered months of 1994, 1999, and 2004. R...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2491625</comments>
            <pubDate>Thu, 18 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2491625</guid>        </item>
        <item>
            <title>Antiretroviral effect of lovastatin on HIV-1-infected individuals without highly active antiretroviral therapy (The LIVE study): a phase-II randomized clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2491627&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F41</link>
            <description>DiscussionPreliminary descriptive studies have suggested that statins (lovastatin) may have anti HIV-1 activity and that their administration is safe,with the potential effect of controlling HIV-1 replication in chronically infected individuals who had not received antiretroviral medications. Considering that there is limited clinical data available on this topic, all these findings warrant further evaluation to determine if long-term administration of statins may benefit the virological and immunological evolution in HIV-1-infected individuals before the use of antiretroviral therapy is required.Trial registration: Registration number NCT00721305. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2491627</comments>
            <pubDate>Wed, 17 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2491627</guid>        </item>
        <item>
            <title>Design of the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study to assess the ability of remote monitoring to treat and triage patients more effectively</title>
            <link>http://www.medworm.com/index.php?rid=2491626&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F42</link>
            <description>Background:
Heart failure patients with implantable defibrillators (ICD) frequently visit the clinic for routine device monitoring. Moreover, in the case of clinical events, such as ICD shocks or alert notifications for changes in cardiac status or safety issues, they often visit the emergency department or the clinic for an unscheduled visit. These planned and unplanned visits place a great burden on healthcare providers.Internet-based remote device interrogation systems, which give physicians remote access to patients' data, are being proposed in order to reduce routine and interim visits and to detect and notify alert conditions earlier.
Methods:
The EVOLVO study is a prospective, randomized, parallel, unblinded, multicenter clinical trial designed to compare remote ICD management with ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2491626</comments>
            <pubDate>Wed, 17 Jun 2009 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2491626</guid>        </item>
        <item>
            <title>Issues in applying multi-arm multi-stage (MAMS) methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial</title>
            <link>http://www.medworm.com/index.php?rid=2480194&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F39</link>
            <description>Conclusions:
It is possible to use the MAMS design to initiate and undertake large scale cancer trials. The results from STAMPEDE will not be known for some years but the lessons learned from running a MAMS trial are shared in the hope that other researchers will use this exciting and efficient method to perform further randomised controlled trials.Trial registrationISRCTN78818544NCT00268476 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2480194</comments>
            <pubDate>Thu, 11 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2480194</guid>        </item>
        <item>
            <title>LOST to follow-up Information in Trials (LOST-IT): a protocol on the potential impact</title>
            <link>http://www.medworm.com/index.php?rid=2480193&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F40</link>
            <description>DiscussionWe aim to make our objectives and methods transparent. The results of this study may have important implications for both clinical trialists and users of the medical literature. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2480193</comments>
            <pubDate>Thu, 11 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2480193</guid>        </item>
        <item>
            <title>Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy</title>
            <link>http://www.medworm.com/index.php?rid=2460609&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F38</link>
            <description>DiscussionThe first patient entered the trial on September, 2008. Up to April 7, 2009, 810 patients had been included in 35 centers. The mean age was 69 (Standard deviation: 10), 18% had a baseline serum creatinine &gt;1.5mg/dL, 57% were diabetics and 13% had a history of heart failure. The ongoing ACT Trial is the largest multicentre RCT that will determine whether acetylcysteine is effective in decreasing the risk of CIN in patients at risk undergoing angiography. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2460609</comments>
            <pubDate>Thu, 04 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2460609</guid>        </item>
        <item>
            <title>Making trials matter: pragmatic and explanatory trials and the problem of applicability</title>
            <link>http://www.medworm.com/index.php?rid=2460610&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F37</link>
            <description>Randomised controlled trials are the best research design for decisions about the effect of different interventions but randomisation does not, of itself, promote the applicability of a trial's results to situations other than the precise one in which the trial was done. While methodologists and trialists have rightly paid great attention to internal validity, much less has been given to applicability.This narrative review is aimed at those planning to conduct trials, and those aiming to use the information in them. It is intended to help the former group make their trials more widely useful and to help the latter group make more informed decisions about the wider use of existing trials. We review the differences between the design of most randomised trials (which have an explanatory attit...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2460610</comments>
            <pubDate>Wed, 03 Jun 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2460610</guid>        </item>
        <item>
            <title>VITA-D: Cholecalciferol substitution in vitamin D deficient kidney transplant recipients: A randomized, placebo-controlled study to evaluate the post-transplant outcome</title>
            <link>http://www.medworm.com/index.php?rid=2444364&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F36</link>
            <description>Background:
Vitamin D does not only regulate calcium homeostasis but also plays an important role as an immune modulator. It influences the immune system through the induction of immune shifts and regulatory cells resulting in immunologic tolerance. As such, vitamin D is thought to exert beneficial effects within the transplant setting, especially in kidney transplant recipients, considering the high prevalence of vitamin D deficiency in kidney transplant recipients.
Methods:
The VITA-D study, a randomized, placebo-controlled, double-blind study with two parallel groups including a total of 200 kidney transplant recipients, is designed to investigate the immunomodulatory and renoprotective effects of cholecalciferol (vitamin D3) within the transplant setting. Kidney transplant recipients f...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2444364</comments>
            <pubDate>Fri, 29 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2444364</guid>        </item>
        <item>
            <title>Over 50 years of trial in Acta Psychiatrica Scandinavica: a survey</title>
            <link>http://www.medworm.com/index.php?rid=2437882&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F35</link>
            <description>Conclusions:
Acta Psychiatrica Scandinavica is a major source of trials. The standard of reporting is similar to other journals but better adherence to CONSORT would ensure higher quality of reports and better dissemination. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2437882</comments>
            <pubDate>Wed, 27 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2437882</guid>        </item>
        <item>
            <title>The HAC Trial (Harmonic for Acute Cholecystitis) Study. Randomized, double-blind, controlled trial of Harmonic(H) versus Monopolar Diathermy (M) for laparoscopic cholecystectomy (LC) for acute cholecystitis (AC) in adults</title>
            <link>http://www.medworm.com/index.php?rid=2434572&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F34</link>
            <description>Background:
In the developmental stage of laparoscopic cholecystectomy (LC) it was considered 'unsafe' or 'technically difficult' to perform laparoscopic cholecystectomy for acute cholecystitis (AC). With increasing experience in laparoscopic surgery, a number of centers have reported on the use of laparoscopic cholecystectomy for acute cholecystitis, suggesting that it is technically feasible but at the expense of a high conversion rate, which can be up to 35 per cent and common bile duct lesions.The HARMONIC SCALPEL(R) (H) is the leading ultrasonic cutting and coagulating surgical device, offering surgeons important benefits including: minimal lateral thermal tissue damage, minimal charring and desiccation.Harmonic Scalpel technology reduces the need for ligatures with simultaneous cutti...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2434572</comments>
            <pubDate>Tue, 26 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2434572</guid>        </item>
        <item>
            <title>Outcome based subgroup analysis: a neglected concern</title>
            <link>http://www.medworm.com/index.php?rid=2425367&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F33</link>
            <description>Conclusions:
A greater level of awareness about the practice and pitfalls of outcome based subgroup analysis is needed. When required, such an analysis should maintain the integrity of randomization. This issue needs greater practical and methodologic attention than has been accorded to it thus far. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2425367</comments>
            <pubDate>Wed, 20 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2425367</guid>        </item>
        <item>
            <title>Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia.</title>
            <link>http://www.medworm.com/index.php?rid=2419607&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F31</link>
            <description>DiscussionThe implementation of the protocol presented here shows that it is possible to create a network of community psychiatric services that accept the idea of using their everyday clinical practice to produce randomised knowledge. The employed pragmatic attitude allowed to randomly allocate more than 100 individuals, which means that this study is the largest antipsychotic combination trial conducted so far in Western countries. We expect that the current project, by generating evidence on whether it is clinically useful to combine clozapine with aripiprazole rather than with haloperidol, provides physicians with a solid evidence base to be directly applied in the routine care of patients with schizophrenia. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419607</comments>
            <pubDate>Fri, 15 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419607</guid>        </item>
        <item>
            <title>The CHOLEGAS Study: Multicentric randomized, blinded, controlled trial of Gastrectomy plus Prophylactic Cholecystectomy versus Gastrectomy only, in adults submitted to Gastric cancer surgery with curative intent.</title>
            <link>http://www.medworm.com/index.php?rid=2419606&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F32</link>
            <description>Background:
The incidence of gallstones and gallbladder sludge is known to be higher in patients after gastrectomy than in general population. This higher incidence is probably related to surgical dissection of the vagus nerve branches and the anatomical gastrointestinal reconstruction. Therefore, some surgeons perform routine concomitant cholecystectomy during standard surgery for gastric malignancies. However, not all the patients who are diagnosed to have cholelithiasis after gastric cancer surgery will develop symptoms or require additional surgical treatments and a standard laparoscopic cholecystectomy is feasible even in those patients who underwent previous gastric surgery. At the present, no randomized study has been published and the decision of gallbladder management is left to e...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2419606</comments>
            <pubDate>Fri, 15 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2419606</guid>        </item>
        <item>
            <title>A clinical evaluation of amlexanox oral adhesive pellicles in the treatment of recurrent aphthous stomatitis and comparison with amlexanox oral tablets: a randomized, placebo controlled, blinded, multicenter clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2393308&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F30</link>
            <description>Amlexanox has been developed as a 5% topical oral paste for the treatment of patients with RAS in most European countries. However, it is not available in China yet or has not been generally accepted in clinical treatment. To explore the effectiveness of amlexanox oral adhesive pellicles in the treatment of minor recurrent aphthous ulcers, and compare it with amlexanox oral adhesive tablets for analysing the difference between the two dosage forms of amlexanox, a randomized, blinded, placebo controlled, parallel, multicenter clinical study was designed. A total of 216 patients with Minnor recurrent aphthous ulcers (MiRAU) were recruited and randomized to amlexanox pellicles or placebo pellicles. Pellicles were consecutively applied 4 times per day for five days. The size and pain level of ...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2393308</comments>
            <pubDate>Wed, 06 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2393308</guid>        </item>
        <item>
            <title>Reporting of harm in randomized controlled trials evaluating stents for percutaneous coronary intervention</title>
            <link>http://www.medworm.com/index.php?rid=2393309&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F29</link>
            <description>Conclusions:
Several harm-related data were not adequately accounted for in articles of randomized controlled trials assessing stents for percutaneous coronary intervention.
Trials manuscript: 5534201182098351 (T80802P) (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2393309</comments>
            <pubDate>Mon, 04 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2393309</guid>        </item>
        <item>
            <title>Protocol for the PINCER trial: a cluster randomised trial comparing the effectiveness of a pharmacist-led IT-based intervention with simple feedback in reducing rates of clinically important errors in medicines management in general practices</title>
            <link>http://www.medworm.com/index.php?rid=2384329&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F28</link>
            <description>DiscussionAt the time of submission of this article, 72 general practices have been recruited (36 in each arm of the trial) and the interventions have been delivered. Analysis has not yet been undertaken.
Trial registration: Current controlled trials ISRCTN21785299 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2384329</comments>
            <pubDate>Fri, 01 May 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2384329</guid>        </item>
        <item>
            <title>Design, analysis, and presentation of crossover trials</title>
            <link>http://www.medworm.com/index.php?rid=2384330&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F27</link>
            <description>Conclusions Reports of crossover trials frequently omit important methodological issues in design, analysis, and presentation. Guidelines for the conduct and reporting of crossover trials might improve the conduct and reporting of studies using this important trial design. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2384330</comments>
            <pubDate>Thu, 30 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2384330</guid>        </item>
        <item>
            <title>Protocol for the Proactive or Reactive Telephone Smoking CeSsation Support (PORTSSS) Trial</title>
            <link>http://www.medworm.com/index.php?rid=2371478&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F26</link>
            <description>DiscussionThe PORTSSS trial will provide high quality evidence to determine the most appropriate kind of counselling which should be provided via the NHS Smoking Helpline and also whether or not an additional offer of cost-free NRT is effective and cost effective for smoking cessation.
Trial Registration (clinicaltrials.gov):	NCT00775944 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2371478</comments>
            <pubDate>Tue, 28 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2371478</guid>        </item>
        <item>
            <title>The design and protocol of acupuncture for migraine prophylaxis: A multicenter randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2360670&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F25</link>
            <description>DiscussionThe study design and the long term clinical practice of acupuncturists guarantee a high external validity for the results. The results of our trial will be helpful to supply the evidence on the efficacy of acupuncture for migraine prophylaxis in China. 
Trial Registration: 
The trial is registered at Controlled Clinical Trials: ISRCTN49839714. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2360670</comments>
            <pubDate>Fri, 24 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2360670</guid>        </item>
        <item>
            <title>The ANTOP study: focal psychodynamic psychotherapy, cognitive-behavioural therapy, and treatment-as-usual in outpatients with anorexia nervosa - a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2360672&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F23</link>
            <description>DiscussionThe study design surmounts the disadvantages of previous studies in that it provides a randomized controlled design, a large sample size, adequate inclusion criteria, an adequate treatment protocol, and a clear separation of the treatment conditions in order to avoid contamination. Nevertheless, the study has to deal with difficulties specific to the psychopathology of anorexia nervosa. The treatment protocol allows for dealing with the typically occurring medical complications without dropping patients from the protocol. However, because patients are difficult to recruit and often ambivalent about treatment, a drop-out rate of 30% is assumed for sample size calculation. Due to the ethical problem of denying active treatment to patients with anorexia nervosa, the control group is...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2360672</comments>
            <pubDate>Thu, 23 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2360672</guid>        </item>
        <item>
            <title>Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2360671&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F24</link>
            <description>DiscussionIt is necessary to assess the effectiveness of pharmacological and psychological treatments for pain catastrophizing in fibromyalgia. This randomized clinical trial will determine whether both treatments are effective for this important prognostic variable in patients with fibromyalgia.
Trial registration: Current Controlled Trials ISRCTN10804772. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2360671</comments>
            <pubDate>Thu, 23 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2360671</guid>        </item>
        <item>
            <title>Rationale and design: telepsychology service delivery for depressed elderly veterans</title>
            <link>http://www.medworm.com/index.php?rid=2350779&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F22</link>
            <description>We describe an ongoing four-year prospective, randomized clinical trial comparing the effectiveness of an empirically supported treatment for major depressive disorder, Behavioral Activation, delivered either via in-home videoconferencing technology (&quot;Telepsychology&quot;) or traditional face-to-face services (&quot;Same-Room&quot;). Our hypothesis is that in-home Telepsychology service delivery will be equally effective as the traditional mode (Same-Room). Two-hundred twenty-four (224) male and female elderly participants will be administered protocol-driven individual Behavioral Activation therapy for depression over an 8-week period; and subjects will be followed for 12-months to ascertain longer-term effects of the treatment on three outcomes domains: (1) clinical outcomes (symptom severity, social f...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2350779</comments>
            <pubDate>Mon, 20 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2350779</guid>        </item>
        <item>
            <title>How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design - a reanalysis of 4 trials</title>
            <link>http://www.medworm.com/index.php?rid=2334743&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F21</link>
            <description>Conclusions:
Multi-arm, multi-stage trials are an effective way of speeding up the therapy evaluation process. The design performs well in terms of the type I and II error rates. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2334743</comments>
            <pubDate>Fri, 17 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2334743</guid>        </item>
        <item>
            <title>Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of depression in acute coronary syndrome (DECARD)</title>
            <link>http://www.medworm.com/index.php?rid=2311366&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F20</link>
            <description>DiscussionThis is the first study of prevention of depression in patients after acute coronary syndrome with a selective serotonin reuptake inhibitor.
Trial registration: www.ClinicalTrials.gov. Identifier: NCT00140257 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2311366</comments>
            <pubDate>Tue, 07 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2311366</guid>        </item>
        <item>
            <title>Anaesthesiological strategies in elective craniotomy: randomized, equivalence, open trial - the NeuroMorfeo trial</title>
            <link>http://www.medworm.com/index.php?rid=2311367&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F19</link>
            <description>We presented the development phase of this anaesthesiological on-going trial. The recruitment started December 4th, 2007 and up to 4th, December 2008, 314 patients have been enrolled. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2311367</comments>
            <pubDate>Mon, 06 Apr 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2311367</guid>        </item>
        <item>
            <title>The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2): a randomised trial to determine the effectiveness and cost-effectiveness of adding a complex intervention for major depressive disorder to usual care for cancer patients</title>
            <link>http://www.medworm.com/index.php?rid=2311369&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F18</link>
            <description>Background:
Depression Care for People with Cancer is a complex intervention delivered by specially trained cancer nurses, under the supervision of a psychiatrist. It is given as a supplement to the usual care for depression, which patients receive from their general practitioner and cancer service. In a 'proof of concept' trial (Symptom Management Research Trials in Oncology-1) Depression Care for People with Cancer improved depression more than usual care alone. The second Symptom Management Research Trial in Oncology (SMaRT Oncology-2 Trial) will test its effectiveness and cost-effectiveness in a 'real world' setting.DesignA two arm parallel group multi-centre randomised controlled trial.
Trial Procedures
500 patients will be recruited through established systematic Symptom Monitoring S...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2311369</comments>
            <pubDate>Mon, 30 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2311369</guid>        </item>
        <item>
            <title>Towards agreement on best practice for publishing raw clinical trial data</title>
            <link>http://www.medworm.com/index.php?rid=2278711&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F17</link>
            <description>Many research-funding agencies now require open access to the results of research they have funded, and some also require that researchers make available the raw data generated from that research. Similarly, the journal Trials aims to address inadequate reporting in randomised controlled trials, and in order to fulfil this objective, the journal is working with the scientific and publishing communities to try to establish best practice for publishing raw data from clinical trials in peer-reviewed biomedical journals. Common issues encountered when considering raw data for publication include patient privacy - unless explicit consent for publication is obtained - and ownership, but agreed-upon policies for tackling these concerns do not appear to be addressed in the guidance or mandates cur...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2278711</comments>
            <pubDate>Wed, 18 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2278711</guid>        </item>
        <item>
            <title>Paying clinicians to join clinical trials: a review of guidelines and interview study of trialists</title>
            <link>http://www.medworm.com/index.php?rid=2252293&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F15</link>
            <description>Conclusions:
Payment of clinicians beyond expenses is perceived to be a less important motivating factor than researching important, salient questions, and facilitating research by reducing bureaucracy and delay. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2252293</comments>
            <pubDate>Tue, 10 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2252293</guid>        </item>
        <item>
            <title>New therapeutic approach to Tourette Syndrome in children based on a randomized placebo-controlled double-blind phase IV study of the effectiveness and safety of magnesium and vitamin B6</title>
            <link>http://www.medworm.com/index.php?rid=2252292&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F16</link>
            <description>This study was funded by the Health Department of the Andalusian Regional Government and by the Healthcare Research Fund of the Carlos III Healthcare Institute (Spanish Ministry of Health).
Trial Registration: Current Controlled Trials ISRCTN41082378 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2252292</comments>
            <pubDate>Tue, 10 Mar 2009 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">2252292</guid>        </item>
        <item>
            <title>The clinically-integrated randomized trial: proposed novel method for conducting large trials at low cost</title>
            <link>http://www.medworm.com/index.php?rid=2239811&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F14</link>
            <description>Conclusions:
The proposed clinically-integrated randomized trial may allow us to enlarge dramatically the number of clinical questions that can be addressed by randomization. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2239811</comments>
            <pubDate>Thu, 05 Mar 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2239811</guid>        </item>
        <item>
            <title>Metformin treatment in diabetes and heart failure: when academic equipoise meets clinical reality</title>
            <link>http://www.medworm.com/index.php?rid=2199818&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F12</link>
            <description>ObjectiveMetformin has had a 'black box' contraindication in diabetic patients with heart failure (HF), but many believe it to be the treatment of choice in this setting. Therefore, we attempted to conduct a pilot study to evaluate the feasibility of undertaking a large randomized controlled trial with clinical endpoints.Study DesignThe pilot study was a randomized double blinded placebo controlled trial. Patients with HF and type 2 diabetes were screened in hospitals and HF clinics in Edmonton, Alberta, Canada (population ~1 million). Major exclusion criteria included the current use of insulin or high dose metformin, decreased renal function, or a glycosylated hemoglobin (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2199818</comments>
            <pubDate>Mon, 09 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2199818</guid>        </item>
        <item>
            <title>Metformin Treatment in Diabetes and Heart Failure: When Academic Equipoise Meets Clinical Reality?</title>
            <link>http://www.medworm.com/index.php?rid=2172410&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F12</link>
            <description>ObjectiveMetformin has had a 'black box' contraindication in diabetic patients with heart failure (HF), but many believe it to be the treatment of choice in this setting. Therefore, we attempted to conduct a pilot study to evaluate the feasibility of undertaking a large randomized controlled trial with clinical endpoints. 
Study Design: The pilot study was a randomized double blinded placebo controlled trial. Patients with HF and type 2 diabetes were screened in hospitals and HF clinics in Edmonton, Alberta, Canada (population ~ 1 million). Major exclusion criteria included the current use of insulin or high dose metformin, decreased renal function, or a glycosylated hemoglobin (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2172410</comments>
            <pubDate>Mon, 09 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2172410</guid>        </item>
        <item>
            <title>The challenges faced in the design, conduct and analysis of surgical RCTs</title>
            <link>http://www.medworm.com/index.php?rid=2167155&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F9</link>
            <description>This article will consider the design, conduct and analysis of a randomised controlled trial of a surgical intervention. The issues will be reviewed under three headings: the timing of the evaluation, defining the research question and trial design issues. Recommendations on the conduct of future surgical RCTs are made. Collaboration between research and surgical communities is needed to address the distinct issues raised by the assessment of surgical interventions and enable the conduct of appropriate and well designed trials. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2167155</comments>
            <pubDate>Fri, 06 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2167155</guid>        </item>
        <item>
            <title>Study protocol: Couples Partnering for Lipid Enhancing Strategies (CouPLES) - a randomized controlled trial</title>
            <link>http://www.medworm.com/index.php?rid=2167154&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F10%2F1%2F10</link>
            <description>DiscussionGiven the social context in which self-management occurs, interventions that teach spouses to provide instrumental and emotional support may help patients initiate and adhere to behaviors that lower their LDL-C levels. Moreover, allowing patients to retain autonomy by deciding which behaviors they would like to change and how may improve adherence and clinical outcomes.
Trial Registration: The ClinicalTrials.gov registration number is NCT00321789. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2167154</comments>
            <pubDate>Fri, 06 Feb 2009 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2167154</guid>        </item>
        <item>
            <title>Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences [POPA study: Prevention of Postoperative Adhesions on behalf of the World Society of Emergency Surgery]</title>
            <link>http://www.medworm.com/index.php?rid=2137196&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F74</link>
            <description>Background:
Adhesive small intestine occlusion [ASIO] is an important cause of hospital admission placing a substantial burden on healthcare systems worldwide. Often times, ASIO is associated with significant morbidity and mortality.Icodextrin 4% solution [Adept, Shire Pharmaceuticals, UK] is a high-molecular-weight a-1,4 glucose polymer that is approved in Europe for use as an intra-operative lavage and a post-operative instillate to reduce the occurrence of post-surgery intra-abdominal adhesions.There are no randomized trials on the use of this solution to prevent adhesions after ASIO operation in current medical literature.The current clinical study evaluates the safety and effectiveness of Icodextrin 4% for decreasing the incidence, extent, and severity of adhesions in patients after a...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2137196</comments>
            <pubDate>Thu, 18 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2137196</guid>        </item>
        <item>
            <title>Prospective controlled randomized trial on prevention of postoperative abdominal adhesions by Icodextrin 4% solution after laparotomic operation for small bowel obstruction caused by adherences 
(POPA study: Prevention of Postoperative Adhesions)</title>
            <link>http://www.medworm.com/index.php?rid=2052176&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F74</link>
            <description>Background:
Adhesive small intestine occlusion (ASIO) is an important cause of hospital admission placing a substantial burden on healthcare systems worldwide. Often times, ASIO is associated with significant morbidity and mortality.
Icodextrin 4% solution (Adept, Shire Pharmaceuticals, UK) is a high-molecular-weight a-1,4 glucose polymer that is approved in Europe for use as an intra-operative lavage and a post-operative instillate to reduce the occurrence of post-surgery intra-abdominal adhesions.
There are no randomized trials on the use of this solution to prevent adhesions after ASIO operation in current medical literature. 
The current clinical study evaluates the safety and effectiveness of Icodextrin 4% for decreasing the incidence, extent, and severity of adhesions in patients aft...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2052176</comments>
            <pubDate>Thu, 18 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2052176</guid>        </item>
        <item>
            <title>A randomized, double blind, crossover, placebo-controlled clinical trial to assess the effects of a mouthwash containing chlorine dioxide on oral malodor</title>
            <link>http://www.medworm.com/index.php?rid=2026292&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F71</link>
            <description>Conclusion:
In this explorative study, ClO2 mouthwash was effective at reducing morning malodor for 4 hours when used by healthy subjects.
Trial registration: ClinicalTrials.gov NCT00655772 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2026292</comments>
            <pubDate>Tue, 09 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2026292</guid>        </item>
        <item>
            <title>Study Protocol: effects of acupuncture on hot flushes in perimenopausal and postmenopausal women - a multicenter randomized clinical trial</title>
            <link>http://www.medworm.com/index.php?rid=2010806&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F70</link>
            <description>This study consists of a multi-center randomized controlled trial with 2 parallel arms. Participants included in the study will meet the following criteria: 1) a documented daily average hot flush score [greater than or equal to]10 for one week prior to the screening visit 2) not taking HRT and other pharmaceutical therapies which might affect hot flushes or other vasomotor symptoms. 
While maintaining usual care, the treatment group will receive acupuncture 3 times a week, for a total of 12 sessions over 4 weeks. The control group will receive usual care alone during the same period. Post-treatment follow-up will be performed one month after completing 12 sessions of acupuncture.DiscussionThis trial will provide evidence for the effectiveness of acupuncture as a treatment for hot flushes....</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2010806</comments>
            <pubDate>Wed, 03 Dec 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">2010806</guid>        </item>
        <item>
            <title>Early intervention in panic: randomized controlled trial and cost-effectiveness analysis</title>
            <link>http://www.medworm.com/index.php?rid=1996102&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F67</link>
            <description>This study was designed to evaluate the (cost) effectiveness of an early intervention based on cognitive behavioural principles. The strong external validity is one of the strengths of the study design. 
Trial registration: Current Controlled Trials ISRCTN33407455. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1996102</comments>
            <pubDate>Thu, 27 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1996102</guid>        </item>
        <item>
            <title>Reporting of clinical trials: a review of research funders' guidelines</title>
            <link>http://www.medworm.com/index.php?rid=1989777&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F66</link>
            <description>Conclusion:
Our review indicates that there is a need to provide more detailed guidance for those conducting and reporting clinical trials to help prevent the selective reporting of results. Statements found in the guidelines generally refer to publication bias rather than outcome reporting bias. Current guidelines need to be updated and include the statement that all primary and secondary outcomes prespecified in the protocol should be fully reported and should not be selected for inclusion in the final report based on their results. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1989777</comments>
            <pubDate>Tue, 25 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1989777</guid>        </item>
        <item>
            <title>ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial</title>
            <link>http://www.medworm.com/index.php?rid=1974547&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F63</link>
            <description>Conclusion:
There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally.Trial RegistrationNumber: ISRCTN36729271 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1974547</comments>
            <pubDate>Fri, 07 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1974547</guid>        </item>
        <item>
            <title>ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2x2 factorial community randomized trial</title>
            <link>http://www.medworm.com/index.php?rid=1938438&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F63</link>
            <description>Conclusion:
There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally.
Trial Registration Number: ISRCTN36729271 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1938438</comments>
            <pubDate>Fri, 07 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1938438</guid>        </item>
        <item>
            <title>Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies</title>
            <link>http://www.medworm.com/index.php?rid=1933776&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F62</link>
            <description>DiscussionThis paper outlines the protocol for a pragmatic randomised trial of a multi-faceted, community-based intervention to optimize the implementation of evidence based management for patients at risk for falls and osteoporosis.
Trial Registration: This trial has been registered with clinicaltrials.gov (ID: NCT00465387) (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1933776</comments>
            <pubDate>Tue, 04 Nov 2008 05:00:00 +0100</pubDate>
            <guid isPermaLink="false">1933776</guid>        </item>
        <item>
            <title>Protocol of an expertise based randomized trial comparing surgical Venae Sectio versus radiological Puncture of Vena Subclavia for insertion of Totally Implantable Access Port in oncological patients
(PORTAS 2 Trial: NCT 006600444)</title>
            <link>http://www.medworm.com/index.php?rid=1905293&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F60</link>
            <description>Background:
Totally Implantable Access Ports (TIAP) are being extensively used world-wide and can be expected to further gain importance with the introduction of new neoadjuvant and adjuvant treatments in oncology. Two different techniques for the implantation can be selected: A direct puncture of a central vein and the utilization of a Seldinger device or the surgical Venae sectio. It is still unclear which technique has the optimal benefit/risk ratio for the patient.DesignA single-center, expertise based randomized, controlled superiority trial to compare two different TIAP implantation techniques. 100 patients will be included and randomized pre-operatively. All patients aged 18 years or older scheduled for primary elective implantation of a TIAP under local anesthesia who signed the in...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1905293</comments>
            <pubDate>Fri, 24 Oct 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1905293</guid>        </item>
        <item>
            <title>Perioperative oxygen fraction - effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial</title>
            <link>http://www.medworm.com/index.php?rid=1900872&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F58</link>
            <description>Discussion This trial assesses benefits and harms of a high inspiratory oxygen fraction, and the trial may be generalizable to a general surgical population undergoing laparotomy.
Trial registration ClinicalTrials.gov identifier: NCT00364741. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1900872</comments>
            <pubDate>Wed, 22 Oct 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1900872</guid>        </item>
        <item>
            <title>European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial</title>
            <link>http://www.medworm.com/index.php?rid=1836990&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F55</link>
            <description>Background:
Renal failure is a frequent complication of multiple myeloma and when severe is associated with a greatly increased morbidity and mortality. The principal cause of severe renal failure in this setting is cast nephropathy, a direct consequence of high concentrations of monoclonal free light chains (FLCs) in the patient's serum. FLC removal by extended haemodialysis, using a high cut-off dialyser, has recently been described as a novel therapeutic option in this setting.  
Methods:
The EUropean trial of free LIght chain removal by exTEnded haemodialysis in cast nephropathy (EuLITE) trial is a prospective, randomised, multicentre, open label clinical trial to investigate the clinical benefit of FLC removal haemodialysis in patients with cast nephropathy, dialysis dependent acute r...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1836990</comments>
            <pubDate>Sun, 28 Sep 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1836990</guid>        </item>
        <item>
            <title>A pragmatic cluster randomised controlled trial to evaluate the safety, clinical effectiveness, cost effectiveness and satisfaction with point of care testing in a general practice setting – rationale, design and baseline characteristics</title>
            <link>http://www.medworm.com/index.php?rid=1725870&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F50</link>
            <description>DiscussionThe paper provides an overview of the Trial Design, the rationale for the research methodology chosen and how the Trial was implemented in a GP environment. The evaluation protocol and data collection processes took into account the large number of patients, the broad range of practice types distributed over a large geographic area, and the inclusion of pathology test results from multiple pathology laboratories.The evaluation protocol developed reflects the complexity of the Trial setting, the Trial Design and the approach taken within the funding provided. The PoCT Trial is regarded as a pragmatic RCT, evaluating the effectiveness of implementing PoCT in GP and every effort was made to ensure that, in these circumstances, internal and external validity was maintained.Trial Regi...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1725870</comments>
            <pubDate>Wed, 06 Aug 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1725870</guid>        </item>
        <item>
            <title>Meta-analysis of trials comparing anastrozole and tamoxifen for adjuvant treatment of postmenopausal women with early breast cancer</title>
            <link>http://www.medworm.com/index.php?rid=1663692&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F47</link>
            <description>ObjectiveIt was aimed to review the literature and make a meta-analysis of the trials on both upfront, switching, and sequencing anastrozole in the adjuvant treatment of early breast cancer.
Methods:
The PubMed, ClinicalTrials.gov and Cochrane databases were systematically reviewed for randomized-controlled trials comparing anastrozole with tamoxifen in the adjuvant treatment of early breast cancer. 
Results:
The combined hazard rate of 4 trials for event-free survival (EFS) was 0.77 (95%CI: 0.70-0.85) (P (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1663692</comments>
            <pubDate>Tue, 29 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1663692</guid>        </item>
        <item>
            <title>Informed consent for clinical trials in acute coronary syndromes and stroke following the European Clinical Trials Directive: investigators' experiences and attitudes</title>
            <link>http://www.medworm.com/index.php?rid=1645471&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F45</link>
            <description>Conclusions:
An update of national and European regulations is required to enable implementation of the emergency trial consent model referred to in GCP guidelines. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1645471</comments>
            <pubDate>Mon, 21 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1645471</guid>        </item>
        <item>
            <title>Rationale, Design and Methodology for a Prospective Randomized Study of graft patency in Off-pump and On-pump MultI-Vessel coronary artery bypasS Surgery (PROMISS) using multidetector computed tomography</title>
            <link>http://www.medworm.com/index.php?rid=1634647&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F44</link>
            <description>Conclusion:
The PROMISS trial aims to shed new light on the effect of Off-Pump as compared to On-Pump coronary artery bypass surgery on graft patency, assessed by multidetector computed tomography, in unselected patients with multivessel coronary artery disease. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1634647</comments>
            <pubDate>Thu, 17 Jul 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1634647</guid>        </item>
        <item>
            <title>The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=1560127&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F37</link>
            <description>Background:
Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit.DesignInternational, multi-centre, prospective, randomized, open, blinded endpoint (PROBE) trial of intravenous rt-PA in acute ischaemic stroke. Suitable patients must be assessed and able to start treatment within 6 hours of developing symptoms, and brain imaging must have excluded intracerebral haemorrhage. With 1000 patients, the trial can detect a 7% absolute difference in the primary outcome. With3500 patients, it can detect a 4.0% absolute benefit &amp; with 6000, (mostly treated between 3 &amp; 6 hours), it can detect a 3% benefit.Trial proceduresPatients...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1560127</comments>
            <pubDate>Tue, 17 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1560127</guid>        </item>
        <item>
            <title>The third international stroke trial 
(IST-3) of thrombolysis for acute ischaemic stroke</title>
            <link>http://www.medworm.com/index.php?rid=1525532&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F37</link>
            <description>Background:
Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DesignInternational, multi-centre, prospective, randomized, open, blinded endpoint (PROBE) trial of intravenous rt-PA in acute ischaemic stroke. Suitable patients must be assessed and able to start treatment within 6 hours of developing symptoms, and brain imaging must have excluded intracerebral haemorrhage. With 1000 patients, the trial can detect a 7% absolute difference in the primary outcome. With 3500 patients, it can detect a 4.0% absolute benefit &amp; with 6000, (mostly treated between 3 &amp; 6 hours), it can detect a 3% benefit. 
Trial procedures: 
P...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1525532</comments>
            <pubDate>Tue, 17 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1525532</guid>        </item>
        <item>
            <title>The SU.FOL.OM3 Study:  a secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or n-3 PUFA on fatal and non fatal cardiovascular events. Design, methods and participants characteristics</title>
            <link>http://www.medworm.com/index.php?rid=1507512&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F35</link>
            <description>Conclusions:
Baseline socio-demographic and medical characteristics of participants are totally comparable in the four randomized groups.
Trial registration: Current Controlled Trials ISRCTN41926726 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1507512</comments>
            <pubDate>Tue, 10 Jun 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1507512</guid>        </item>
        <item>
            <title>Competing Risk and Heterogeneity of Treatment Effect in Clinical Trials</title>
            <link>http://www.medworm.com/index.php?rid=1460764&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F30</link>
            <description>It has been demonstrated that patients enrolled in clinical trials frequently have a large degree of variation in their baseline risk for the outcome of interest. Thus, some have suggested that clinical trial results should routinely be stratified by outcome risk using risk models, since the summary results may otherwise be misleading. However, variation in competing risk is another dimension of risk heterogeneity that may also underlie treatment effect heterogeneity. Understanding the effects of competing risk heterogeneity may be especially important for pragmatic comparative effectiveness trials, which seek to include traditionally excluded patients, such as the elderly or complex patients with multiple comorbidities. Indeed, the observed effect of an intervention is dependent on the ra...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1460764</comments>
            <pubDate>Thu, 22 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1460764</guid>        </item>
        <item>
            <title>Review of &quot;Interpreting and Reporting Clinical Trials. A guide to the CONSORT statement and the principles of randomised controlled trials&quot; by Anthony Keech, Val Gebski and Rhana Pike</title>
            <link>http://www.medworm.com/index.php?rid=1453965&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F27</link>
            <description>n/a (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1453965</comments>
            <pubDate>Mon, 19 May 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1453965</guid>        </item>
        <item>
            <title>Effectiveness of computer-tailored Smoking Cessation Advice in Primary Care (ESCAPE): a Randomised Trial</title>
            <link>http://www.medworm.com/index.php?rid=1406660&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F23</link>
            <description>DiscussionComputer tailored personal feedback, adapted to reading levels and motivation to quit, is a simple and inexpensive intervention which could be widely replicated and delivered cost effectively to a large proportion of the smoking population. Given its recruitment potential, a modest success rate could have a large effect on public health. The intervention also fits into the broader scope of tobacco control, by prompting more quit attempts, and increasing referrals to specialised services. The provision of this option to smokers in primary care can complement existing services, and work synergistically with other measures to produce more quitters and reduce the prevalence of smoking in the UK. 
Trial registration: Current Controlled Trials ISRCTN05385712 (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1406660</comments>
            <pubDate>Tue, 29 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1406660</guid>        </item>
        <item>
            <title>An assessment of the quality of randomised controlled trials conducted in China</title>
            <link>http://www.medworm.com/index.php?rid=1396066&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F22</link>
            <description>Conclusions:
Reporting of RCTs in China requires substantial improvement to meet the targets of the CONSORT statement. The conduct of Chinese RCTs cannot be directly inferred from the standard of reporting; however without good reporting the methods of the trials cannot be clearly ascertained. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1396066</comments>
            <pubDate>Thu, 24 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1396066</guid>        </item>
        <item>
            <title>Streamlining tasks and roles to expand treatment and care for HIV: randomised controlled trial protocol</title>
            <link>http://www.medworm.com/index.php?rid=1393638&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F21</link>
            <description>Background:
A major barrier to accessing free government-provided antiretroviral treatment (ART) in South Africa is the shortage of suitably skilled health professionals. Current South African guidelines recommend that only doctors should prescribe ART, even though most primary care is provided by nurses. We have developed an effective method of educational outreach to primary care nurses in South Africa. Evidence is needed as to whether primary care nurses, with suitable training and managerial support, can initiate and continue to prescribe and monitor ART in the majority of ART-eligible adults. 
Methods/design: This is a protocol for a pragmatic cluster randomised trial to evaluate the effectiveness of a complex intervention based on and supporting nurse-led antiretroviral treatment (AR...</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1393638</comments>
            <pubDate>Wed, 23 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1393638</guid>        </item>
        <item>
            <title>Endorsement of the CONSORT Statement by high impact factor medical journals: a survey of journal editors and journal 'Instructions to Authors'</title>
            <link>http://www.medworm.com/index.php?rid=1382206&amp;cid=s_34098_22_f&amp;fid=34098&amp;url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F9%2F1%2F20</link>
            <description>Conclusions:
Journals should be more explicit in their recommendations and expectations of authors regarding the CONSORT Statement and related CONSORT extensions papers. (Source: Trials)</description>
            <author>Trials</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1382206</comments>
            <pubDate>Fri, 18 Apr 2008 04:00:00 +0100</pubDate>
            <guid isPermaLink="false">1382206</guid>        </item>
    </channel>
</rss>
